Skip to main content
. 2019 Jan 8;9:1154. doi: 10.3389/fneur.2018.01154

Table 2.

Distribution characteristics of plaque of patients.

Non-enhancement (%) Mild enhancement (%) Marked enhancement (%)
Group ACU 0 3 (9.7%) 28 (90.3%)
Group CHR 0 3 (23.1%) 10 (76.9%)
Group NON 8 (28.6%) 6 (21.4%) 14 (50%)

Group ACU, the acute/sub-acute phase culprit plaque group; Group CHR, the chronic-phase culprit plaque group; Group NON, the non-culprit plaque group.